Protecting Australia And The Region From Emerging And Re-emerging Infectious Diseases.
Funder
National Health and Medical Research Council
Funding Amount
$774,540.00
Summary
The world is facing unprecedented threats from epidemics. In 2014 Ebola showed that issues such as quarantine, personal protective equipment and improved health system capacity are just as critical as drugs and vaccines, yet these are under-researched. Professor MacIntyre is an international expert epidemic control. She will lead a strategic research program to improve control of emerging and re-emerging infections, using her expertise in vaccines, personal protective equipment and biosecurity.
Assessing Vaccine Effectiveness Of Publicly Funded Vaccination Programs In Queensland
Funder
National Health and Medical Research Council
Funding Amount
$99,883.00
Summary
I will measure how well three vaccines on the national immunisation schedule prevent disease in Queensland. Pertussis (whooping cough), rotavirus, and varicella (chicken-pox) vaccines will be assessed using routinely collected health data, such as disease notifications and hospitalisations, and vaccination data. The findings of this research will contribute to evaluating the effectiveness of these publicly funded vaccination programs and will provide an evidence base for future decision-making.
Towards Global Control Of Scabies: Advances In Diagnosis, Treatment And Community Control
Funder
National Health and Medical Research Council
Funding Amount
$340,891.00
Summary
The scabies mite causes severe itch and rash and leads to infections, kidney and heart disease. Scabies affects up to 50% of children in Indigenous communities. We now know most scabies can be prevented, so we urgently need to find the most effective strategies. My research will develop new tests to help doctors to accurately diagnose scabies. I will test new medicines to treat scabies and strategies to prevent scabies and its complications in children, families and entire populations.
Prevention Of Pertussis From Birth Through Maternal Immunisation
Funder
National Health and Medical Research Council
Funding Amount
$197,657.00
Summary
Whooping cough or pertussis is a significant cause of death in infants worldwide. Newborns remain at risk until they have received 1 to 2 doses of pertussis vaccine (around 4 months of age). My project involves investigating whether giving pertussis vaccine in the third trimester of pregnancy provides passive protection (via transplacental transfer of antibody) to the infant in sufficient levels for protection against whooping cough in early infancy.